Indivior Pharmaceuticals Inc ( INDV) - Stock Earnings
INDV Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
INDV Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 102.0 million USD | 358.0 million USD |
| 2026Q1 | 89.0 million USD | 317.0 million USD |
| 2026Q2 | 122.0 million USD | 343.0 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
INDV Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -129.0 million USD | 1.1 billion USD |
| 2024 | 2.0 million USD | 1.2 billion USD |
| 2025 | 210.0 million USD | 1.2 billion USD |
| 2026 Est. | — | — |
INDV
Price: $34.16
52 week price:
Earnings Per Share: 2.79 USD
P/E Ratio: 13.79
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 4.5 billion